Clinical Trial Update: Safety and Efficacy Evaluation of Intracoronary Infusion of Allogeneic Human Cardiac Stem Cells in Patients With AMI [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating intracoronary infusion of allogeneic human cardiac stem cells in patients with acute myocardial infarction has completed, assessing s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Allogeneic human cardiac stem cells (allogeneic human cardiac stem cells)

Snippet

Sponsor: Coretherapix | Conditions: Acute Myocardial Infarction | Phase 1, Phase 2 | Status: COMPLETED